Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.400
+0.200 (6.25%)
At close: May 30, 2025, 4:00 PM
3.440
+0.040 (1.18%)
After-hours: May 30, 2025, 7:11 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $136.88 million as of May 30, 2025. Its market cap has decreased by -60.42% in one year.
Market Cap
136.88M
Enterprise Value
105.12M
1-Year Change
-60.42%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $136.88M, a decrease of -89.74%. That is a compound annual growth rate of -38.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 136.88M | -48.95% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.72B |
| Johnson & Johnson | 366.16B |
| AbbVie | 323.96B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 272.36B |
| Abbott Laboratories | 230.48B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |